Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2003
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363934A1 Template-fixed peptidomimetics with antimicrobial activity
11/26/2003EP1363675A2 Compositions useful in gene therapy
11/26/2003EP1363653A2 Methods and compositions for enhancing angiogenesis
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0859627B1 Mimicking peptides in cancer therapy
11/26/2003EP0821002B1 Plant cell growth factors
11/26/2003CN1458839A Dental products comprising bone growth enhancing peptide
11/25/2003US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS)
11/25/2003US6653442 Protegrins
11/25/2003US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/25/2003CA2086888C Whooping cough vaccine
11/20/2003WO2003096022A2 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095477A2 Miniprotein ligands and other polypeptides and methods for making and using same
11/20/2003WO2003095475A2 Peptide compounds and their use as protease substrates
11/20/2003WO2003095474A2 Peptides and methods for the control of obesity
11/20/2003WO2003094972A2 Fap-activated anti-tumor prodrugs
11/20/2003WO2003074546A8 Streptavidin-binding peptide
11/20/2003WO2003066849A3 Novel purified polypeptides from staphylococcus aureus
11/20/2003WO2003045993A3 Protein biopolymer markers predictive of type ii diabetes
11/20/2003WO2003020764A3 Modified factor ix
11/20/2003WO2003016331A3 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2002070698A3 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity
11/20/2003WO2002064734A3 Identification of target-specific folding sites in peptides and proteins
11/20/2003WO2002057794A3 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies
11/20/2003WO2002055547A3 Sfrp and peptide motifs that interact with sfrp and methods of their use
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003US20030216325 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
11/20/2003US20030216322 Containing the motif E(L/V/S)RGDS
11/20/2003US20030216320 Peptide-based multimeric targeted contrast agents
11/20/2003US20030216307 Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release
11/20/2003US20030216296 Amino acid sequences that mediate effective delivery of nucleic acids into cells and tissues, optionally using liposomes
11/20/2003US20030215846 Methods of constructing and screening diverse expression libraries
11/20/2003US20030215460 Methods and compositions for inducing an immune response
11/20/2003US20030215456 Administering either sequentially in any order or simultaneously amounts of at least two therapeutic agents selected from a compound which is a PSA conjugate and a tachykinin receptor antagonist
11/20/2003CA2524862A1 Peptides and methods for the control of obesity
11/20/2003CA2485437A1 Peptide compounds and their use as protease substrates
11/20/2003CA2484607A1 Methods and compositions for inducing an immune response
11/20/2003CA2484211A1 Screening for peptides inhibiting pp1c binding to bcl-2, bcl-xl and bcl-w proteins
11/19/2003EP1362865A1 Cyclic peptide
11/19/2003EP1362599A2 Conjugate of bioegradable aliphatic polyester-based polymer with peptide
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1361893A1 Modified anti-egfr antibodies with reduced immunogenicity
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003EP0756449B1 Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
11/19/2003CN1457340A Petrides and derivatives thereof showing cell attachment, spreading and detachment activity
11/18/2003US6649592 Peptide inhibitors of LFA-1/ICAM-1 interaction
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003093304A1 Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
11/13/2003WO2003093302A2 Process for the synthesis of peptides amides by side-chain attachement to a solid phase
11/13/2003WO2003093301A2 Process for the synthesis of peptides
11/13/2003WO2003093300A2 Anti-microbial peptides and compositions
11/13/2003WO2003093294A2 Conformationally constrained peptides that bind the orl-1 receptor
11/13/2003WO2003092736A2 Peptide nucleic acid conjugates with transporter peptides
11/13/2003WO2003092632A2 Cyclic peptide anti-cancer agents and methods
11/13/2003WO2003092631A2 Cyclic peptide anti-viral agents and methods
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092605A2 Protease inhibitors
11/13/2003WO2003076621A3 Vpr modulators and uses thereof
11/13/2003WO2003064614A3 Transport peptides and uses therefor
11/13/2003WO2003064447A3 Immune-modulating peptide
11/13/2003WO2003010281A3 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
11/13/2003WO2002055486A3 Triazene compounds and use thereof
11/13/2003US20030212253 Comprises peptide which binds to fibrinogen and serves as a modulator of enzyme activity; for increasing the half- life of proteins and pro-drugs in circulation; for treatment of arteriosclerosis and emphysema
11/13/2003US20030212249 Synthesis of cyclosporin analogs
11/13/2003US20030212002 Peptide for controlling appetite
11/13/2003US20030212001 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions
11/13/2003US20030211998 Brain disorders; cardiovascular disorders
11/13/2003US20030211997 Mimetic peptides for an epitope of apolipoprotein B-100, concatemers of the peptides, and modified peptides, and compositions comprising the same
11/13/2003US20030211992 Method for treating cartilage disorders
11/13/2003US20030211980 Antibody; controlling cell activation
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211476 Modulating protein expression/translation/concentration in cells; vaccine/drug delivery
11/13/2003US20030211471 Method for detecting ligands and targets in a mixture
11/13/2003US20030211079 Immobilization with polyoxyethylene glycol; adjust circulation half-life
11/13/2003US20030211078 Therapy for restenosis; antiischemic agents; antitumor agents; anticancer agents; complexing
11/13/2003CA2484551A1 Smart pro-drugs of serine protease inhibitors
11/13/2003CA2484189A1 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/12/2003EP1361439A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins
11/12/2003EP1361285A2 Protein kinase peptide substrate determination using peptide libraries
11/12/2003EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof
11/12/2003EP1360500A2 Methods for selective targeting
11/12/2003EP1360201A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity
11/12/2003EP1360189A1 Formulation of boronic acid compounds
11/12/2003EP1359941A2 Albumin-based drug delivery system and antimicrobial peptides
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1359931A1 Prevention of diabetes by administration of gnrh antagonists
11/12/2003EP1359930A2 Novisprins: antimicrobial peptides
11/12/2003EP1117677B1 Ligand presenting assembly (lpa), method of preparation and uses thereof
11/12/2003EP0886648B1 Compounds and peptides that bind to the erythropoietin receptor
11/12/2003EP0817650B1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/12/2003EP0773952B1 Interaction trap systems for detecting protein interactions
11/12/2003CN1454494A Albumen oligo peptide and preparing method thereof
11/12/2003CN1127569C Method for mass production of antimicrobial peptide
11/12/2003CN1127515C Process for preparing certain AzA
11/12/2003CN1127514C Antineoplastic peptides
11/12/2003CN1127477C Methods and compositions for lipidization of hydrophilic molecules
1 ... 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 ... 423